Home
Conditions
Hematologic Diseases

Clinical trial condition

Hematologic Diseases

Explore clinical trials studying Hematologic Diseases. Study availability and eligibility vary by location and protocol.

15,392 public trials 2,847 recruiting studies

Refine in advanced search Browse all conditions

Hematologic Diseases trial results

Completed

THAL-DEX Incorporated Into Double PBSC Autotransplantation for Untreated Multiple Myeloma (MM)

NCT01341262

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations: Not specified

View Trial Details

Completed

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma

NCT00470405

Conditions: Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +47 more
Locations: Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States

View Trial Details

Completed

Study of Dasatinib (BMS-354825) in Patients With Accelerated Phase Chronic Myeloid Leukemia

NCT00101647

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +12 more
Locations: Local Institution Birmingham, Alabama, United States

Local Institution Anaheim, California, United States

Local Institution Los Angeles, California, United States

Local Institution Stanford, California, United States

View all 70 locations

View Trial Details

Completed

Protecting Young Special Risk Females From Cervical Cancer Through Human Papilloma Virus (HPV) Vaccination

NCT00964210

Conditions: Arthritis, Arthritis, Juvenile, Autoimmune Diseases, +43 more
Locations: Royal Childrens Hospital Melbourne, Victoria, Australia

View Trial Details

Completed

Lenalidomide Versus Placebo in Myelodysplastic Syndromes With a Deletion 5q[31] Abnormality

NCT00179621

Conditions: Anemia, Bone Marrow Diseases, Hematologic Diseases, +5 more
Locations: AZ St-Jan Brugge AV Bruges, Belgium

UZ Gent Ghent, Belgium

UZ Gasthuisberg Leuven, Belgium

CHU Mont Godine Yvoir, Belgium

View all 38 locations

View Trial Details

Completed

Dasatinib (BMS-354825) in Subjects With Lymphoid Blast Phase Chronic Myeloid Leukemia or Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia

NCT00101595

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +18 more
Locations: Local Institution Birmingham, Alabama, United States

Local Institution Anaheim, California, United States

Local Institution Los Angeles, California, United States

Local Institution Stanford, California, United States

View all 60 locations

View Trial Details

Completed

Study of BMS-354825 in Subjects With CML Who Are Resistant to or Intolerant of Imatinib or Ph+All in Japan

NCT00337454

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myelogenous Leukemia, +11 more
Locations: Local Institution Nagoya, Aichi-ken, Japan

Local Institution Nagoya, Aichi-ken, Japan

Local Institution Nagoya, Aichi-ken, Japan

Local Institution Maebashi, Gunma, Japan

View all 21 locations

View Trial Details

Completed

BMS-354825 in Patients With Chronic Accelerated, or Blast Phase Chronic Myelogenous Leukemia or Philadelphia Positive Acute Lymphoblastic Leukemia

NCT00103701

Conditions: Blast Crisis, Bone Marrow Diseases, Bronchial Diseases, +32 more
Locations: Local Institution Los Angeles, California, United States

Local Institution Houston, Texas, United States

View Trial Details

Completed

Prophylaxis Versus On-demand Therapy Through Economic Report

NCT01159587

Conditions: Blood Coagulation Disorders, Blood Coagulation Disorders, Inherited, Coagulation Protein Disorders, +6 more
Locations: Many Locations, Italy

View Trial Details

Completed

Treatment of Children and Adolescents With Refractory or Relapsed Acute Myeloid Leukemia

NCT00186966

Conditions: Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations: St. Jude Children's Research Hospital Memphis, Tennessee, United States

View Trial Details

Hematologic Diseases

Hematologic Diseases trial results

Related conditions